Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
In Memoriam – Gregory A. Curt, MD
lungcanc
Update to the “Molecular Testing Guideline for Selection of Lung Cancer...
lungcanc
Benefit of EGFR Mutation Analysis from Plasma Cell-Free DNA for Treatment...
lungcanc
NCI Corner – Interview with Dinah S. Singer, PHD
lungcanc
Genetic Differences in Lung Cancers Arising in Smokers and Never-Smokers
lungcanc
Roswell Park Cancer Institute to Conduct First CimaVax Trial in the...
lungcanc
Global Nursing Impact of Immunotherapy in Lung Cancer
lungcanc
FDA’s New Tobacco Rule
lungcanc
IASLC WCLC 2016: Active Prevention, Accurate Diagnosis, Advanced Care
lungcanc
Osimertinib: A New Option in Non-Small Cell Lung Cancer – Q&A...
lungcanc
1
...
46
47
48
...
53
Page 47 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
